Avalo Therapeutics (AVTX) Revenue (2016 - 2025)
Avalo Therapeutics' (AVTX) quarterly Revenue came in at $59000.0 in Q4 2025, down 69.27% YoY from $192000.0 in Q4 2024, and down 69.27% on a QoQ basis from $192000.0 in Q4 2024.
Avalo Therapeutics (AVTX) Revenue (2016 - 2025) Analysis & Trends
Avalo Therapeutics (AVTX) has 10 years of Revenue data on file, last reported at $59000.0 in Q4 2025.
- Quarterly Revenue fell 69.27% year-over-year to $59000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $500000.0 (up 13.38% YoY) and the FY2025 annual result came in at $59000.0, down 86.62% from the prior year.
- Revenue eased to $59000.0 in Q4 2025, from $192000.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $14.9 million in Q3 2022 to a low of $59000.0 in Q4 2025.
- A 5-year average of $1.7 million and a median of $571000.0 in 2023 frame the typical range for Revenue.
- Annual changes were most pronounced in 2022 — Revenue surged 1007.33% — and 2023, when it sank 98.42%.
- Tracing AVTX's Revenue over 5 years: stood at $219000.0 in 2021, then surged by 309.13% to $896000.0 in 2022, then plunged by 36.27% to $571000.0 in 2023, then slumped by 66.37% to $192000.0 in 2024, then tumbled by 69.27% to $59000.0 in 2025.
- The last three Revenue figures came in at $59000.0 (Q4 2025), $192000.0 (Q4 2024), and $249000.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Avalo Therapeutics | 854.16 Mn | 453.89 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 59,000.00 |
| Dec 31, 2024 | 192,000.00 |
| Sep 30, 2024 | 249,000.00 |
| Dec 31, 2023 | 571,000.00 |
| Sep 30, 2023 | 236,000.00 |
| Jun 30, 2023 | 643,000.00 |
| Mar 31, 2023 | 475,000.00 |
| Dec 31, 2022 | 896,000.00 |
| Sep 30, 2022 | 14.95 Mn |
| Jun 30, 2022 | 1.03 Mn |
| Mar 31, 2022 | 1.17 Mn |
| Dec 31, 2021 | 219,000.00 |
| Sep 30, 2021 | 1.35 Mn |
| Jun 30, 2021 | 3.36 Mn |
| Mar 31, 2021 | 473,000.00 |
| Dec 31, 2020 | 1.50 Mn |
| Sep 30, 2020 | 1.11 Mn |
| Jun 30, 2020 | 1.34 Mn |
| Mar 31, 2020 | 2.75 Mn |
| Dec 31, 2019 | 4.00 Mn |